Streetbeat News

Stock Prices

EGRX

Eagle Pharmaceuticals experienced a significant stock price movement, triggering a circuit breaker to the upside. Despite this, the stock is currently down by 27.3%.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 1:45 pm

BABA

BIDU

JD

LI

NIO

PDD

XPEV

ZK

Chinese stocks, including Alibaba, NIO, XPeng, and Li Auto, are rallying following China's stimulus plans, which include cutting the reserve requirement ratio and allowing mortgage refinancing. Alibaba is highlighted as a key beneficiary, with increased exposure from investors like David Tepper.

Portfolio Pulse from Anusuya Lahiri

October 02, 2024 | 1:26 pm

AIPI

DAT

PLTR

Palantir Technologies has partnered with Edgescale AI to launch 'Live Edge', a solution to integrate AI in manufacturing and utilities. This partnership aims to simplify infrastructure and enhance operational efficiency. Palantir's stock has risen significantly over the past year, and investors can access it through ETFs like REX AI Equity Premium Income ETF and ProShares Big Data Refiners ETF.

Portfolio Pulse from Nabaparna Bhattacharya

October 02, 2024 | 1:26 pm

NKE

Nike's Q1 revenue missed estimates, causing a decline in shares of footwear and athletic apparel stocks.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 1:25 pm

EGRX

Eagle Pharmaceuticals is set to be delisted from the Nasdaq, leading to a decline in its share price.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 1:22 pm

LI

TSLA

Tesla's Q3 deliveries exceeded consensus but fell short of whisper numbers, causing a 3.5% drop in premarket trading. Concerns include Model Y/3 sales and potential margin erosion from a financing plan in China. Despite strong sales, Tesla's stock remains under pressure.

Portfolio Pulse from Shanthi Rexaline

October 02, 2024 | 1:21 pm

LEVI

Levi Strauss & Co. (NYSE:LEVI) is set to release its Q3 earnings, with analysts expecting an EPS of 31 cents and revenue of $1.55 billion. Recent analyst ratings show mixed sentiments, with price targets ranging from $20 to $28.

Portfolio Pulse from Avi Kapoor

October 02, 2024 | 1:20 pm

EGRX

Eagle Pharmaceuticals will be delisted from Nasdaq on October 3, 2024, due to non-compliance with Nasdaq Listing Rule 5250(c)(1). The company failed to file required financial reports and did not appeal the delisting decision.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 1:20 pm

BABA

JD

LOT

MADE

META

NIO

NKE

NVDA

TSLA

WAY

The article lists the top 10 trending stocks on WallStreetBets as of October 2, 2024, according to Swaggy Stocks. The stocks mentioned are BABA, JD, LOT, MADE, META, NIO, NKE, NVDA, TSLA, and WAY.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 1:18 pm

IBIT

Charles Edwards of Capriole Investments predicts a bullish outlook for Bitcoin, driven by improving macro conditions and the impact of spot ETFs. He notes Bitcoin's correlation with gold and expects it to follow gold's upward trend. Recent inflows into iShares Bitcoin Trust highlight growing institutional interest.

Portfolio Pulse from Khyathi Dalal

October 02, 2024 | 1:16 pm